China · Delayed Price · Currency is CNY Aurisco Pharmaceutical Company Description
Aurisco Pharmaceutical Co.,Ltd. engages in the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations worldwide.
The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs.
It also provides eplerenone, an API to treat cardiovascular diseases, lowering blood pressure, and treating heart failure; futicasone propionate, used for the treatment of asthma, respiratory tract diseases, and rhinitis; Tenofovir, an anti-infection used to treat AIDS and hepatitis B; pregabalin for the treatment of anti-epileptic, analgesic, and anti-anxiety purposes, as well as for neuralgia; abiraterone acetate to treat prostate cancer; and dydrogesterone, to treat endogenous for women’s heath.
Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
| Country | China |
| Founded | 1998 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,026 |
| CEO | Dingjun Chu |
Contact Details
Address: Badu Industrial Park Zone Tiantai, 317200 China | |
| Phone | 86 576 8317 0900 |
| Website | aurisco.com |
Stock Details
| Ticker Symbol | 605116 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000042S4 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Dingjun Chu | GM and Director |
| Xiuyu Wang | Deputy GM, Accounting Supervisor and Financial Director |
| Liqin Zhang | Deputy GM and Director of Sales |
| Guoping Wang | Deputy GM and Director |
| Fangfang Li | Board Secretary |
| Zhenping Zhao | Deputy General Manager |
| Mingyan Xin | Deputy General Manager |
| Jieming Chen | Deputy General Manager |